Taito Fukushima

4PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 27, 2026
Nivolumab Plus Ipilimumab for Unresectable Hepatocellular Carcinoma in Early Real-World Clinical Practice: A Multicenter Analysis of Efficacy and Safety.

|May 13, 2025
Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score-matched analysis.

Taito Fukushima, Satoshi Kobayashi, Hiroyuki Katoh

|May 21, 2024
The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors.

Taito Fukushima, Satoshi Kobayashi, Makoto Ueno

|Apr 06, 2023
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Taito Fukushima, Manabu Morimoto, Satoshi Kobayashi

Pageof 1

Frequent Collaborators

3 joint publications

Satoshi Kobayashi

1 joint publications

Hironao Okubo

1 joint publications

Haruki Uojima

1 joint publications

Satoshi Narahara